Principia of cancer therapy. X. Prostaglandin D2 triggers redifferentiation of the bestatin-treated breast cancer cells in vitro.
D000230:Adenocarcinoma / Q000473:pathology; D000818:Animals; D002471:Cell Transformation, Neoplastic / Q000187:drug effects*; D002478:Cells, Cultured; D005260:Female; D007930:Leucine / Q000031:analogs & derivatives* / Q000494:pharmacology; D008325:Mammary Neoplasms, Experimental / Q000473:pathology*; D051379:Mice; D015230:Prostaglandin D2; D011457:Prostaglandins D / Q000494:pharmacology*
D011457:Prostaglandins D; D007930:Leucine; C012211:ubenimex; D015230:Prostaglandin D2